|
EP2934532B1
(en)
|
2012-12-20 |
2019-10-23 |
Purdue Research Foundation |
Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics
|
|
GB201415347D0
(en)
*
|
2014-08-29 |
2014-10-15 |
Ucl Business Plc |
Signalling system
|
|
HRP20240357T1
(hr)
*
|
2014-12-24 |
2024-06-07 |
Autolus Limited |
Stanica
|
|
HRP20220890T1
(hr)
*
|
2015-02-06 |
2022-10-14 |
National University Of Singapore |
Postupci za povećanje učinkovitosti terapijskih imunosnih stanica
|
|
GB201503742D0
(en)
|
2015-03-05 |
2015-04-22 |
Ucl Business Plc |
Chimeric antigen receptor
|
|
SG11201707182WA
(en)
|
2015-03-05 |
2017-10-30 |
Hutchinson Fred Cancer Res |
Immunomodulatory fusion proteins and uses thereof
|
|
PL3280729T3
(pl)
|
2015-04-08 |
2022-08-22 |
Novartis Ag |
Terapie cd20, terapie cd22 i terapie skojarzone komórką eksprymującą chimeryczny receptor antygenowy (car) cd19
|
|
GB201507119D0
(en)
*
|
2015-04-27 |
2015-06-10 |
Ucl Business Plc |
Nucleic Acid Construct
|
|
GB201507115D0
(en)
*
|
2015-04-27 |
2015-06-10 |
Ucl Business Plc |
Nucleic Acid Construct
|
|
US11173179B2
(en)
|
2015-06-25 |
2021-11-16 |
Icell Gene Therapeutics Llc |
Chimeric antigen receptor (CAR) targeting multiple antigens, compositions and methods of use thereof
|
|
TWI833684B
(zh)
|
2015-06-25 |
2024-03-01 |
美商生物細胞基因治療有限公司 |
嵌合抗原受體（ｃａｒ）、組合物及其使用方法
|
|
CA3019835A1
(en)
|
2016-04-08 |
2017-10-12 |
Purdue Research Foundation |
Methods and compositions for car t cell therapy
|
|
GB201610515D0
(en)
*
|
2016-06-16 |
2016-08-03 |
Autolus Ltd |
Cell
|
|
GB201610512D0
(en)
|
2016-06-16 |
2016-08-03 |
Autolus Ltd |
Chimeric antigen receptor
|
|
CN109562126A
(zh)
|
2016-06-24 |
2019-04-02 |
美商生物细胞基因治疗有限公司 |
嵌合抗原受体(car)、组合物及其使用方法
|
|
CN117298260A
(zh)
*
|
2016-09-02 |
2023-12-29 |
莱蒂恩技术公司 |
用DuoCAR治疗癌症的组合物和方法
|
|
JP7467117B2
(ja)
|
2016-10-07 |
2024-04-15 |
ノバルティス アーゲー |
癌の治療のためのキメラ抗原受容体
|
|
CN118581046A
(zh)
|
2016-11-22 |
2024-09-03 |
新加坡国立大学 |
用于t细胞恶性肿瘤免疫疗法的cd7表达阻滞剂和嵌合抗原受体
|
|
CN110352068A
(zh)
|
2016-12-02 |
2019-10-18 |
南加利福尼亚大学 |
合成的免疫受体及其使用方法
|
|
US11427633B2
(en)
*
|
2016-12-13 |
2022-08-30 |
Crage Medical Co., Limited |
Anti-CD19 humanized antibody and immune effector cell targeting cd 19
|
|
WO2018124766A2
(ko)
*
|
2016-12-28 |
2018-07-05 |
주식회사 녹십자랩셀 |
키메라 항원 수용체 및 이를 발현하는 자연 살해 세포
|
|
WO2018132427A1
(en)
|
2017-01-10 |
2018-07-19 |
The General Hospital Corporation |
Targeted t cells with cytotoxicity toward immunosuppressive cells
|
|
AU2018219226B2
(en)
|
2017-02-07 |
2024-12-19 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Phospholipid ether (PLE) CAR T cell tumor targeting (CTCT) agents
|
|
CN110582288B
(zh)
|
2017-02-28 |
2024-09-20 |
恩多塞特公司 |
用于car t细胞疗法的组合物和方法
|
|
US11725210B2
(en)
|
2017-03-17 |
2023-08-15 |
Fred Hutchinson Cancer Center |
Immunomodulatory fusion proteins and uses thereof
|
|
EP4759318A2
(en)
*
|
2017-04-14 |
2026-06-17 |
The General Hospital Corporation |
Chimeric antigen receptor t cells targeting the tumor microenvironment
|
|
WO2018193231A1
(en)
*
|
2017-04-18 |
2018-10-25 |
Autolus Limited |
Cell
|
|
JP2020517259A
(ja)
*
|
2017-04-19 |
2020-06-18 |
ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム |
操作された抗原受容体を発現する免疫細胞
|
|
AU2018269194B2
(en)
*
|
2017-05-15 |
2025-05-22 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Bicistronic chimeric antigen receptors and their uses
|
|
CN118853581A
(zh)
|
2017-06-21 |
2024-10-29 |
美商生物细胞基因治疗有限公司 |
嵌合抗原受体(CARs)、组合物及其使用方法
|
|
WO2019025800A1
(en)
*
|
2017-08-02 |
2019-02-07 |
Autolus Limited |
CELLS EXPRESSING A CHIMERIC ANTIGENIC RECEPTOR OR A MANIPULATED TCR AND COMPRISING A SELECTIVELY EXPRESSED SELECTIVE NUCLEOTIDE SEQUENCE
|
|
CA3071282A1
(en)
|
2017-08-10 |
2019-02-14 |
National University Of Singapore |
T cell receptor-deficient chimeric antigen receptor t-cells and methods of use thereof
|
|
CN109385402A
(zh)
*
|
2017-08-11 |
2019-02-26 |
上海恒润达生生物科技有限公司 |
一种等比例混合两种靶点cart细胞的制备方法及应用
|
|
CN107446937B
(zh)
*
|
2017-09-05 |
2020-12-25 |
深圳华云生物技术有限公司 |
嵌合抗原受体及其表达基因、光控调节的嵌合抗原受体修饰的t细胞及其应用
|
|
CA3076337A1
(en)
|
2017-09-19 |
2019-03-28 |
Massachusetts Institute Of Technology |
Compositions for chimeric antigen receptor t cell therapy and uses thereof
|
|
EP4279584A3
(en)
*
|
2017-10-16 |
2024-03-06 |
Lentigen Technology, Inc. |
Compositions and methods for treating cancer with anti-cd22 immunotherapy
|
|
US11649294B2
(en)
|
2017-11-14 |
2023-05-16 |
GC Cell Corporation |
Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising same
|
|
CN109988242A
(zh)
*
|
2018-01-02 |
2019-07-09 |
武汉波睿达生物科技有限公司 |
联合嵌合抗原受体、表达载体、慢病毒及t细胞
|
|
CN108101994B
(zh)
*
|
2018-01-04 |
2020-09-15 |
广东万海细胞生物科技有限公司 |
抗cd19抗体及其应用
|
|
WO2019144095A1
(en)
|
2018-01-22 |
2019-07-25 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Methods of use for car t cells
|
|
AU2019218729B2
(en)
|
2018-02-06 |
2025-12-04 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Fluorescein-specific CARs exhibiting optimal T cell function against FL-PLE labelled tumors
|
|
ES3068176T3
(en)
*
|
2018-02-12 |
2026-05-28 |
Massachusetts Gen Hospital |
Chimeric antigen receptor t cells targeting the tumor microenvironment
|
|
CN110157738B
(zh)
*
|
2018-02-13 |
2023-06-27 |
亘喜生物科技（上海）有限公司 |
靶向cd19和cd22的工程化免疫细胞及其应用
|
|
WO2019165121A1
(en)
|
2018-02-21 |
2019-08-29 |
Board Of Regents, The University Of Texas System |
Methods for activation and expansion of natural killer cells and uses therof
|
|
JP7568224B2
(ja)
|
2018-02-23 |
2024-10-16 |
エンドサイト・インコーポレイテッド |
Ｃａｒ ｔ細胞療法のための配列決定法
|
|
GB201807870D0
(en)
|
2018-05-15 |
2018-06-27 |
Autolus Ltd |
A CD79-specific chimeric antigen receptor
|
|
WO2019220109A1
(en)
|
2018-05-15 |
2019-11-21 |
Autolus Limited |
Chimeric antigen receptor
|
|
JP7584299B2
(ja)
|
2018-05-23 |
2024-11-15 |
ナショナル ユニバーシティ オブ シンガポール |
Ｔ細胞悪性腫瘍の免疫療法のためのｃｄ２表面発現の遮断およびキメラ抗原受容体の発現
|
|
KR20210031898A
(ko)
*
|
2018-07-13 |
2021-03-23 |
난징 레전드 바이오테크 씨오., 엘티디. |
전염병을 치료하기 위한 공동수용체 시스템
|
|
SG11202102781UA
(en)
|
2018-09-27 |
2021-04-29 |
Autolus Ltd |
Chimeric antigen receptor
|
|
SG11202100935TA
(en)
|
2018-09-28 |
2021-02-25 |
Massachusetts Inst Technology |
Collagen-localized immunomodulatory molecules and methods thereof
|
|
GB201816522D0
(en)
|
2018-10-10 |
2018-11-28 |
Autolus Ltd |
Methods and reagents for analysing nucleic acids from single cells
|
|
GB201820547D0
(en)
|
2018-12-17 |
2019-01-30 |
Oxford Univ Innovation |
Modified antibodies
|
|
GB201903237D0
(en)
|
2019-03-08 |
2019-04-24 |
Autolus Ltd |
Method
|
|
EP3934666A1
(en)
*
|
2019-03-08 |
2022-01-12 |
Autolus Limited |
Compositions and methods comprising engineered chimeric antigen receptor and modulator of car
|
|
CN113840912A
(zh)
*
|
2019-05-16 |
2021-12-24 |
南京传奇生物科技有限公司 |
包含识别分子的工程化免疫细胞
|
|
AU2020286471B2
(en)
*
|
2019-06-07 |
2025-07-31 |
The Trustees Of The University Of Pennsylvania |
Dual CAR expressing T cells individually linked to CD28 and 4-1BB
|
|
US20220259617A1
(en)
|
2019-06-13 |
2022-08-18 |
The General Hospital Corporation |
Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells
|
|
JP2022538974A
(ja)
|
2019-06-26 |
2022-09-07 |
マサチューセッツ インスチテュート オブ テクノロジー |
免疫調節融合タンパク質－金属水酸化物錯体およびその方法
|
|
GB201910185D0
(en)
|
2019-07-16 |
2019-08-28 |
Autolus Ltd |
Method
|
|
US20220257757A1
(en)
|
2019-07-16 |
2022-08-18 |
Autolus Limited |
Method for preconditioning a subject who is about to receive a t-cell therapy
|
|
GB201910651D0
(en)
|
2019-07-25 |
2019-09-11 |
Autolus Ltd |
Virus-like particle
|
|
CN114929738B
(zh)
*
|
2019-08-07 |
2026-01-02 |
水肺治疗公司 |
抗nampt抗体及其用途
|
|
CN112390891B
(zh)
*
|
2019-08-14 |
2022-06-03 |
苏州方德门达新药开发有限公司 |
嵌合抗原受体及其构建方法和应用
|
|
CN110903401A
(zh)
*
|
2019-11-20 |
2020-03-24 |
浙江大学 |
一种靶向cd19的二代嵌合抗原受体及其表达载体与应用
|
|
JP7805928B2
(ja)
|
2019-11-26 |
2026-01-26 |
ノバルティス アーゲー |
Ｃｄ１９及びｃｄ２２キメラ抗原受容体及びその使用
|
|
WO2021108661A2
(en)
|
2019-11-26 |
2021-06-03 |
Novartis Ag |
Chimeric antigen receptors and uses thereof
|
|
IL295063A
(en)
|
2020-02-04 |
2022-09-01 |
Seattle Childrens Hospital Dba Seattle Childrens Res Inst |
Chimeric antigen receptors (car) against dinitrophenol
|
|
WO2021158534A1
(en)
*
|
2020-02-04 |
2021-08-12 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Methods and compositions for stimulation of chimeric antigen receptor t cells with hapten labelled cells
|
|
CA3174638A1
(en)
|
2020-03-11 |
2021-09-16 |
Fundacio Institut De Recerca Contra La Leucemia Josep Carreras |
Cd22 targeting-moiety for the treatment of b-cell acute lymphoblastic leukemia (b-all)
|
|
US12433954B2
(en)
|
2020-05-01 |
2025-10-07 |
Massachusetts Institute Of Technology |
Methods of activating anti-CD19 chimeric antigen receptor (CAR) T cells using amphiphilic ligand conjugates comprising CAR-targeting protein sequence motifs
|
|
US20210340524A1
(en)
|
2020-05-01 |
2021-11-04 |
Massachusetts Institute Of Technology |
Methods for identifying chimeric antigen receptor-targeting ligands and uses thereof
|
|
GB202006820D0
(en)
*
|
2020-05-07 |
2020-06-24 |
Autolus Ltd |
Cell
|
|
WO2021257679A1
(en)
|
2020-06-17 |
2021-12-23 |
Janssen Biotech, Inc. |
Materials and methods for the manufacture of pluripotent stem cells
|
|
CA3186065A1
(en)
|
2020-07-16 |
2022-01-20 |
Xiaohu FAN |
Cd19 binding molecules and uses thereof
|
|
JP7846667B2
(ja)
|
2020-07-16 |
2026-04-15 |
レジェンド バイオテック アイルランド リミテッド |
Ｃｄ２０結合分子及びその使用
|
|
BR112023001272A2
(pt)
|
2020-07-24 |
2023-04-04 |
Massachusetts Gen Hospital |
Partículas semelhantes a vírus aprimoradas e métodos de uso das mesmas para entrega às células
|
|
AU2021333653A1
(en)
*
|
2020-08-25 |
2023-03-23 |
Cytoimmune Therapeutics, Inc. |
Bispecific antibody car cell immunotherapy
|
|
IL303269A
(en)
|
2020-12-03 |
2023-07-01 |
Century Therapeutics Inc |
Genetically engineered cells and uses thereof
|
|
US11661459B2
(en)
|
2020-12-03 |
2023-05-30 |
Century Therapeutics, Inc. |
Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
|
|
CN112481284B
(zh)
*
|
2020-12-07 |
2023-07-25 |
深圳瑞吉生物科技有限公司 |
一种编码CAR基因的mRNA、组合mRNA、构建方法、CAR-T细胞和应用
|
|
TW202241935A
(zh)
|
2020-12-18 |
2022-11-01 |
美商世紀治療股份有限公司 |
具有可調適受體專一性之嵌合抗原受體系統
|
|
KR102393776B1
(ko)
*
|
2020-12-30 |
2022-05-04 |
(주)이노베이션바이오 |
Cd22에 특이적인 인간화 항체 및 이를 이용한 키메라 항원 수용체
|
|
CA3212006A1
(en)
*
|
2021-02-26 |
2022-09-01 |
Kelonia Therapeutics, Inc. |
Lymphocyte targeted lentiviral vectors
|
|
JP2024507958A
(ja)
|
2021-02-26 |
2024-02-21 |
ナンジン レジェンド バイオテック カンパニー，リミテッド |
外因的に導入されたサイトカインを発現する操作された免疫エフェクター細胞
|
|
US20230174651A1
(en)
|
2021-06-23 |
2023-06-08 |
Janssen Biotech, Inc. |
Materials and methods for hinge regions in functional exogenous receptors
|
|
WO2023016554A1
(zh)
*
|
2021-08-13 |
2023-02-16 |
上海医药集团股份有限公司 |
靶向cd22的抗原结合蛋白及其用途
|
|
KR102829757B1
(ko)
*
|
2021-11-17 |
2025-07-09 |
(주)이노베이션바이오 |
인간화된 cd22에 특이적인 항체 및 이를 이용한 키메라 항원 수용체
|
|
JP2025516531A
(ja)
|
2022-05-11 |
2025-05-30 |
オートラス リミテッド |
高リスクまたは再発性小児急性リンパ芽球性白血病のｃｄ１９／２２ ｃａｒ ｔ細胞処置
|
|
CN119907674A
(zh)
|
2022-07-22 |
2025-04-29 |
詹森生物科技公司 |
遗传指令向效应免疫细胞的增强转移
|
|
US20240197780A1
(en)
*
|
2022-12-19 |
2024-06-20 |
Development Center For Biotechnology |
Chimeric antigen receptors, nucleic acids encoding the same, and uses thereof in treating cancers
|
|
KR20260013442A
(ko)
*
|
2023-03-17 |
2026-01-28 |
카티전 테라퓨틱스, 인코포레이티드 |
키메라 항원 수용체의 장기 발현을 위해 조정된 세포내 신호전달 및 공동자극 도메인
|
|
JP2026519087A
(ja)
|
2023-05-30 |
2026-06-11 |
オートラス リミテッド |
再発型／不応性ｂ細胞性急性リンパ芽球性白血病のｃｄ１９ｃａｒ ｔ細胞処置
|
|
EP4719443A1
(en)
*
|
2023-06-02 |
2026-04-08 |
Northeastern University |
Targeted immune cell therapy utilizing trail and tnf mediated apoptosis
|
|
AU2024365682A1
(en)
|
2023-10-23 |
2026-04-30 |
Autolus Limited |
Products and methods for treating autoimmune diseases
|
|
GB202403564D0
(en)
|
2024-03-12 |
2024-04-24 |
Autolus Ltd |
Method
|
|
WO2025215360A1
(en)
|
2024-04-09 |
2025-10-16 |
Autolus Limited |
Method
|
|
WO2025231185A1
(en)
|
2024-05-01 |
2025-11-06 |
Legend Biotech Ireland Limited |
Viral glycoprotein variants and uses thereof
|
|
NL2037811B1
(en)
|
2024-05-29 |
2025-12-12 |
Univ Oslo |
Treatment for Cancer
|
|
NL2037929B1
(en)
|
2024-06-11 |
2026-01-12 |
Prinses Maxima Centrum Voor Kinderoncologie B V |
Brain Organoid
|
|
WO2026086785A1
(en)
|
2024-10-21 |
2026-04-30 |
Shenzhen Wondercel Biotechnology Limited |
Eukaryotic cells expressing exogenous inosine monophosphate dehydrogenase comprising chimeric antigen receptor binding to gucy2c
|
|
WO2026096515A1
(en)
|
2024-10-28 |
2026-05-07 |
Legend Biotech Ireland Limited |
Viral glycoprotein variants and uses thereof
|
|
GB202417285D0
(en)
|
2024-11-25 |
2025-01-08 |
Univ Oxford Innovation Ltd |
Expanded t cell population
|
|
GB202418460D0
(en)
|
2024-12-16 |
2025-01-29 |
Univ Oxford Innovation Ltd |
Multivalent binding proteins
|